title: Rhabdomyolysis developing secondary to atorvastatin therapy in a patient with liver cirrhosis.
abstract: Atorvastatin is a lipid lowering agent that is widely used worldwide. Rhabdomyolysis is a rare but serious side effect that may lead to renal failure and dangerous electrolyte abnormalities in patients with decreased hepatic clearance of atorvastatin. We herein report the case of a patient with liver cirrhosis receiving atorvastatin therapy for ischemic heart disease and hyperlipidemia who developed rhabdomyolysis and acute renal failure.
authors.affiliation: Department of Internal Medicine, Shiraz University of Medical Sciences, Iran. Eshraghiana@yahoo.com
authors.forename: Ahad
authors.initials: A
authors.lastname: Eshraghian
authors.forename: Amir A'lam
authors.initials: AA
authors.lastname: Kamyab
mesh_terms: D000368:Aged; D000924:Anticholesteremic Agents / Q000009:adverse effects*; D000069059:Atorvastatin; D005260:Female; D006538:Heptanoic Acids / Q000009:adverse effects*; D006801:Humans; D008103:Liver Cirrhosis / Q000175:diagnosis / Q000188:drug therapy*; D011758:Pyrroles / Q000009:adverse effects*; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000175:diagnosis*
chemical_list: D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin